Correlation Between Structure Therapeutics and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Structure Therapeutics and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Structure Therapeutics and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Structure Therapeutics American and X4 Pharmaceuticals, you can compare the effects of market volatilities on Structure Therapeutics and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Structure Therapeutics with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Structure Therapeutics and X4 Pharmaceuticals.
Diversification Opportunities for Structure Therapeutics and X4 Pharmaceuticals
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Structure and XFOR is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Structure Therapeutics America and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Structure Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Structure Therapeutics American are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Structure Therapeutics i.e., Structure Therapeutics and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Structure Therapeutics and X4 Pharmaceuticals
Given the investment horizon of 90 days Structure Therapeutics American is expected to under-perform the X4 Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Structure Therapeutics American is 3.34 times less risky than X4 Pharmaceuticals. The stock trades about -0.08 of its potential returns per unit of risk. The X4 Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 49.00 in X4 Pharmaceuticals on August 25, 2024 and sell it today you would lose (15.00) from holding X4 Pharmaceuticals or give up 30.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Structure Therapeutics America vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Structure Therapeutics |
| X4 Pharmaceuticals |
Structure Therapeutics and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Structure Therapeutics and X4 Pharmaceuticals
The main advantage of trading using opposite Structure Therapeutics and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Structure Therapeutics position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Structure Therapeutics vs. Day One Biopharmaceuticals | Structure Therapeutics vs. X4 Pharmaceuticals | Structure Therapeutics vs. Inozyme Pharma | Structure Therapeutics vs. Acumen Pharmaceuticals |
| X4 Pharmaceuticals vs. Eliem Therapeutics | X4 Pharmaceuticals vs. HCW Biologics | X4 Pharmaceuticals vs. Scpharmaceuticals | X4 Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |